Science Explorer Back to mapMap
Discussion
Company · New Brunswick · United States

MentiNova (United States)

mentinova.comROR OpenAlex
Research works
1
▼ 100% vs 2018-21
Citations
10
11.5 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
23%
world 40%
MentiNova (United States)

Not ranked overall: MentiNova (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does MentiNova (United States) work in?

In all years, 67% of research at MentiNova (United States) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (67%), Biochemistry, Genetics and Molecular Biology (22%), Neuroscience (11%).

Health Sciences: 1 fractional works · 66.7% of its workMedicine: 1 fractional works · 66.7% of its workLife Sciences: 0 fractional works · 33.3% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 22.2% of its workNeuroscience: 0 fractional works · 11.1% of its workALL ITS WORKMentiNova (UnitedStates)1fractional works, all years
Life Sciences33%Health Sciences67%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Medicine166.7%
    1. Biochemistry, Genetics and Molecular Biology022.2%
    2. Neuroscience011.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from MentiNova (United States)?

The most cited paper from MentiNova (United States) is "Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of P arkinson disease" (Lisa F. Potts, Eun Su Park, Jong‐Min Woo et al., 2015), with 51 citations. Next come "Abstract 2217: Concordance of PIK3CA mutations in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer: A systematic literature review" (0) and "Abstract 2193: Biopsy and analytical testing methods used to identify PIK3CA mutations in hormone receptor-positive, human epidermal growth factor receptor-negative metastatic breast cancer: A systematic literature review" (0).

Most cited papers
#PaperReleasedCitations
1 Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of P arkinson disease Lisa F. Potts, Eun Su Park, Jong‐Min Woo et al. · Annals of Neurology Open access 27 Mar 2015 51
2 Abstract 2217: Concordance of PIK3CA mutations in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer: A systematic literature review Alejandra Aguilar, Joni L. Dean, Elizabeth J. Anderson et al. · Cancer Research Review Jul 2018 0
3 Abstract 2193: Biopsy and analytical testing methods used to identify PIK3CA mutations in hormone receptor-positive, human epidermal growth factor receptor-negative metastatic breast cancer: A systematic literature review Elizabeth J. Anderson, Lea E. Mollon, Alejandra Aguilar et al. · Cancer Research Review Jul 2018 0
All 3 most cited papers, with filters and sorting

Which research topics does MentiNova (United States) publish most on?

By volume: Advanced Breast Cancer Therapies, Cancer Diagnosis and Treatment, Neurotransmitter Receptor Influence on Behavior and Cancer Genomics and Diagnostics.

Advanced Breast Cancer T…0Advanced Breast Cancer Therapies: 0 fractional worksCancer Diagnosis and Tre…0Cancer Diagnosis and Treatment: 0 fractional worksNeurotransmitter Receptor Influence on Behavior: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksNeurological disorders a…0Neurological disorders and treatments: 0 fractional worksParkinson's Disease Mech…0Parkinson's Disease Mechanisms and Treatments: 0 fractional worksBreast Cancer Treatment …0Breast Cancer Treatment Studies: 0 fractional works
Pulmonary and Respiratory MedicineOncologyCellular and Molecular NeuroscienceCancer Research1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  2. 2 Cancer Diagnosis and Treatment Oncology 0 works
  3. 3 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 0 works
  5. 5 Neurological disorders and treatments Neurology 0 works
  6. 6 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  7. 7 Breast Cancer Treatment Studies Cancer Research 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.1%not open76.9%

World: 40% of research is openly available.

Other research institutions in New Brunswick

All research institutions in New Brunswick

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about MentiNova (United States). Posts are plain text and can be reported.